[Effect of sodium nucleinate on the clinical and immunological indicators in infectious-allergic bronchial asthma]. 1981

V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva

UI MeSH Term Description Entries
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D008231 Lymphopenia Reduction in the number of lymphocytes. Lymphocytopenia,Lymphocytopenias,Lymphopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009696 Nucleic Acids High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages. Nucleic Acid,Acid, Nucleic,Acids, Nucleic
D011749 Pyrogens Substances capable of increasing BODY TEMPERATURE and cause FEVER and may be used for FEVER THERAPY. They may be of microbial origin, often POLYSACCHARIDES, and may contaminate distilled water. Pyrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva
January 1990, Journal of hygiene, epidemiology, microbiology, and immunology,
V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva
January 1990, Terapevticheskii arkhiv,
V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva
January 1983, Terapevticheskii arkhiv,
V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva
January 1989, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva
March 1988, Klinicheskaia meditsina,
V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva
November 1979, Antibiotiki,
V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva
May 1968, Terapevticheskii arkhiv,
V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva
January 1984, Sovetskaia meditsina,
V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva
August 1986, Klinicheskaia meditsina,
V P Sil'vestrov, and V M Provotorov, and A M Zemskov, and A V Nikitin, and I V Vuravleva
January 1984, Vutreshni bolesti,
Copied contents to your clipboard!